Abstract | BACKGROUND: METHODS: In this study, Ad2/ betaARKct was infused into the balloon-injured site of rabbit iliac arteries using a porous infusion catheter over 2 min. Twenty-eight days after gene transfer, angiographic and histological assessments were performed. RESULTS: CONCLUSIONS: These results suggest that adenoviral-mediated gene transfer of betaARKct is a clinically viable cytostatic gene therapy strategy for the treatment of restenosis.
|
Authors | Zhengyu Luo, Maria Palasis, Midori Yamakawa, Louis X Liu, Karen A Vincent, Leonard Trudell, Geoffrey A Akita, Walter J Koch, Seng H Cheng, Richard J Gregory, Canwen Jiang |
Journal | The journal of gene medicine
(J Gene Med)
Vol. 6
Issue 10
Pg. 1061-8
(Oct 2004)
ISSN: 1099-498X [Print] England |
PMID | 15386742
(Publication Type: Journal Article)
|
Copyright | Copyright (c) 2004 John Wiley & Sons, Ltd. |
Chemical References |
- DNA Primers
- Cyclic AMP-Dependent Protein Kinases
- beta-Adrenergic Receptor Kinases
- beta-Galactosidase
|
Topics |
- Adenoviridae
(genetics)
- Angiography
- Animals
- Carotid Arteries
(pathology)
- Constriction, Pathologic
(prevention & control, therapy)
- Cyclic AMP-Dependent Protein Kinases
(chemistry, genetics)
- DNA Primers
(chemistry)
- Gene Transfer Techniques
- Genetic Therapy
(methods)
- Genetic Vectors
- Hyperplasia
(pathology, therapy)
- Iliac Artery
(pathology)
- Protein Structure, Tertiary
- Rabbits
- Time Factors
- Tunica Intima
(pathology)
- beta-Adrenergic Receptor Kinases
- beta-Galactosidase
(metabolism)
|